However, they generally failed to reach statistical significance for primary subclinical atherosclerosis endpoints ( 124 ) ( 125 ).
← all excerpts
Systemic lupus erythematosus-driven accelerated atherosclerosis: the immune-metabolic-vascular axis and therapeutic implications.
1
—
—